ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MDGS Medigus Ltd

2.36
0.00 (0.00%)
After Hours
Last Updated: 01:00:00
Delayed by 15 minutes
Name Symbol Market Type
Medigus Ltd NASDAQ:MDGS NASDAQ Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 2.36 2.52 2.59 0 01:00:00

Report of Foreign Issuer (6-k)

23/01/2017 12:08pm

Edgar (US Regulatory)



 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
 
For the month of January 2017
 
Commission File Number 001-37381
 
MEDIGUS   LTD.
(Translation of registrant's name into English)
 
Omer Industrial Park, No. 7A, P.O. Box 3030, Omer 8496500, Israel
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
 
Form 20-F ☒      Form 40-F ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   __
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):   __
 

EXPLANATORY NOTE
 
On January 23, 2017, Medigus Ltd. issued a press release titled: "Medigus Receives First Purchase Order for MUSE TM in Italy." A copy of this press release is furnished herewith as exhibit 99.1.

This Form 6-K is incorporated by reference into the Company's Registration Statement on Form F-3 filed with the Securities and Exchange Commission on August 24, 2016 (Registration No. 333-213280) and its Registration Statement on Form S-8 filed with the Securities and Exchange Commission on September 9, 2015 (Registration No. 333-206803).



SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
MEDIGUS LTD.
 
 
 
 
 
Date: January 23, 2017
By:
/s/ Christopher Rowland
 
 
 
Christopher Rowland
 
 
 
Chief Executive Officer
 
 

EXHIBIT INDEX
 
Exhibit Description
   
99.1  
Press release titled: "Medigus Receives First Purchase Order for MUSE TM in Italy," dated January 23, 2017.
 


 

1 Year Medigus Chart

1 Year Medigus Chart

1 Month Medigus Chart

1 Month Medigus Chart

Your Recent History

Delayed Upgrade Clock